US2010111961A1PendingUtilityA1

Compositions and methods for diagnosing or treating psoriasis

56
Assignee: CELLTECH R & D INCPriority: Nov 28, 2000Filed: Oct 13, 2009Published: May 6, 2010
Est. expiryNov 28, 2020(expired)· nominal 20-yr term from priority
A61P 17/06C07K 14/4713C07K 14/47
56
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

In one aspect, the present invention provides isolated nucleic acid molecules that encode a CAN-1 polypeptide, or an STG polypeptide. In another aspect, the present invention also provides isolated STG polypeptides, isolated CAN-1 polypeptides, and isolated SEEK-1 polypeptides. In another aspect, the present invention provides isolated antibodies that bind specifically to a CAN-1, SEEK-1 or STG polypeptide. In another aspect, the present invention provides methods of diagnosing or predicting the susceptibility to psoriasis of an individual. In another aspect, the present invention provides methods for ameliorating the symptoms and/or progression of psoriasis.

Claims

exact text as granted — not AI-modified
1 - 50 . (canceled) 
     
     
         51 . A method for ameliorating the symptoms and/or progression of psoriasis, the method comprising the step of administering to an individual suffering from psoriasis an inhibitory amount of a selective inhibitor of a polypeptide chosen from the group consisting of CAN-1, STG and SEEK-1, wherein the inhibitory amount of the selective inhibitor causes a reduction in the amount and/or activity of the polypeptide. 
     
     
         52 - 57 . (canceled) 
     
     
         58 . A method according to  claim 51  wherein said polypeptide inhibits CAN-1 and is encoded by SEQ ID No. 10.

Cited by (0)

No later patents cite this yet.

References (0)

No backward citations on record.